MKI67 and breast cancer: BC-PDE proliferation (Ki67+ve) ranged from 0–40%, intrinsic tumour apoptosis (cPARP+ve) ranged from 0 to 22% and necrosis area ranged from 0 to 45% (Fig. 1A).